Skip to main content

Peer Review reports

From: MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder

Original Submission
9 Sep 2021 Submitted Original manuscript
7 Oct 2021 Reviewed Reviewer Report
17 Dec 2021 Reviewed Reviewer Report
27 Feb 2022 Author responded Author comments - Kexin Xu
Resubmission - Version 2
27 Feb 2022 Submitted Manuscript version 2
4 Mar 2022 Author responded Author comments - Kexin Xu
Resubmission - Version 3
4 Mar 2022 Submitted Manuscript version 3
30 Mar 2022 Reviewed Reviewer Report
8 Apr 2022 Reviewed Reviewer Report
17 Apr 2022 Author responded Author comments - Kexin Xu
Resubmission - Version 4
17 Apr 2022 Submitted Manuscript version 4
18 Apr 2022 Author responded Author comments - Kexin Xu
Resubmission - Version 5
18 Apr 2022 Submitted Manuscript version 5
20 Apr 2022 Author responded Author comments - Kexin Xu
Resubmission - Version 6
20 Apr 2022 Submitted Manuscript version 6
Publishing
25 Apr 2022 Editorially accepted
17 May 2022 Article published 10.1186/s12885-022-09606-0

You can find further information about peer review here.

Back to article page